Efficacy and Safety of Injectable Dulaglutide 1.5 mg Among Type 2 Diabetes Patients in Clinics at King Saud Medical City, Riyadh, Saudi Arabia.

Mashael Saad Albargawi Rawan Naser Alharbi Mohammad Abbas Alajlani Ibtihal Abdulwarith Abdulaal Lina Othman Aldakhil

Published in: Journal of epidemiology and global health (2024)

Dulaglutide is a safe and effective therapy that demonstrated favorable glycemic control and weight reduction in obese type 2 diabetes patients of Saudi origin.

Keyphrases

type diabetes
glycemic control
saudi arabia
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
weight loss
prognostic factors
cardiovascular disease
body mass index
primary care
physical activity
insulin resistance
metabolic syndrome
blood glucose
bone marrow
patient reported